Pharmaceuticals News

Press Releases from Pharmaceuticals Companies

Newsroom

Pharmaceuticals news releases from pharmaceuticals companies published by Newsfile. Searches will return results from stories up to two years old.

PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to announce that, further to its news releases dated April 2, 2025 and April 14, 2025, it has closed an initial tranche (the "Initial Tranche") of its previously...
Biotechnology, Pharmaceuticals, Health
2025-04-28 4:00 PM EDT | PreveCeutical Medical Inc.
Theralase Discovers New Mechanism of Action of Lead Drug
Toronto, Ontario--(Newsfile Corp. - April 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-04-28 7:00 AM EDT | Theralase Technologies Inc.
InsuJet Distribution Expands Across Canada
Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is please to report that distribution of The InsuJet™ will be expanded with increased availability across Canada connecting alongside health professionals."Following its...
Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-24 4:30 PM EDT | NuGen Medical Devices Inc.
Telescope Innovations Presents Results of Second Fiscal Quarter 2025
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") a developer of advanced technologies and services for the global pharmaceutical and chemical industries, reports financial results for the fiscal quarter ended February 28, 2025 (Q2)....
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-04-23 11:56 PM EDT | Telescope Innovations Corp.
Hemostemix Engages PatentVest to Strengthen its Global Patent Portfolio
Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) a leader in the development of autologous stem cell therapy for the treatment of cardiovascular diseases, announces its partnership with PatentVest. PatentVest, a subsidiary of MDB Capital (NASDAQ: MDBH), is a premier intellectual property...
Biotechnology, Pharmaceuticals, Health
2025-04-23 11:53 AM EDT | Hemostemix Inc.
Maxwell Biosciences Secures Anti-Diarrheal US Military Agreement
Austin, Texas--(Newsfile Corp. - April 23, 2025) - Maxwell Biosciences, a preclinical drug platform company that develops ClaromersTM, synthetic small molecules that mimic and improve upon the natural immune system, today announced a new collaboration. Maxwell has entered into a Limited Purpose Cooperative Research and Development Agreement (LP-CRADA) with the...
Biotechnology, Pharmaceuticals
2025-04-23 9:00 AM EDT | Maxwell Biosciences, Inc.
NervGen Pharma to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 21, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today announced its participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto, ON. Mike Kelly, President & CEO, is scheduled to...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-21 7:30 AM EDT | NervGen Pharma Corp.
Quantum BioPharma Corporate Update
Toronto, Ontario--(Newsfile Corp. - April 18, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-04-18 8:00 PM EDT | Quantum BioPharma Ltd.
Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
New York, New York--(Newsfile Corp. - April 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") announced today that it received a notification letter dated April 16, 2025, from the Listings Qualifications Department (the "Staff") of the Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-04-17 7:17 PM EDT | Psyence Biomed
Medexus Successfully Completes Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in Quebec, Canada
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 17, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a listing agreement with the provincial government of Quebec for Trecondyv® (treosulfan for injection). The Public Prescription Drug Insurance Plan of the Régie de l'Assurance Maladie du Québec, or RAMQ, will...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-17 7:00 AM EDT | Medexus Pharmaceuticals Inc.
Beyond Medical Technologies Announces Filing of Application for Management Cease Trade Order
Vancouver, British Columbia--(Newsfile Corp. - April 16, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") announced today that it will likely miss its filing deadline of April 30, 2025 to file audited annual financial statements and accompanying management's discussion and...
Technology, Pharmaceuticals, Health
2025-04-16 7:02 PM EDT | Beyond Medical Technologies Inc.
Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement
New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company") today announced a strategic follow-on investment of USD $500,000 into PsyLabs, a privately-held company specializing in the production of psychedelic active pharmaceutical ingredients (APIs) and extracts for research, clinical trials,...
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-04-15 8:30 AM EDT | Psyence Biomed
PreveCeutical Announces Up-Sized Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that, further to its news release dated April 2, 2025, that the Company will be increasing the size of its previously announced non- brokered private placement (the...
Biotechnology, Pharmaceuticals, Health
2025-04-14 9:45 PM EDT | PreveCeutical Medical Inc.
Beyond Medical Technologies Closes Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) ("Beyond Medical" or the "Company") is pleased to announce the successful closing of its previously announced non-brokered private placement financing for total gross proceeds of for total gross proceeds...
Technology, Pharmaceuticals, Health
2025-04-14 8:00 PM EDT | Beyond Medical Technologies Inc.
Theralase(R) Closes Non-Brokered Private Placement
Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-04-14 4:22 PM EDT | Theralase Technologies Inc.
Telescope Innovations to Present at the Planet MicroCap Showcase: VEGAS on April 23, 2025
Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company today announced that it will be presenting...
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-04-14 3:17 PM EDT | Telescope Innovations Corp.
Liviniti Named to Modern Healthcare's 2025 Innovators List
Award honors top healthcare companies that are propelling the industry forward Natchitoches, Louisiana--(Newsfile Corp. - April 14, 2025) - Liviniti, a national leader in PBM transparency and prescription drug savings, has been named one of the top healthcare innovators for 2025. The Modern Healthcare Innovators Awards recognize organizations and leaders...
Pharmaceuticals, Health
2025-04-14 10:38 AM EDT | Liviniti
Neural Therapeutics Strengthens IP Portfolio With a Patent Application
Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline DosesExtraction Technology Delivering Higher Yields and Greater PurityFrankfurt Stock Exchange Ticker Symbol Changed to "HANF"Extension of LOI with CWE European Holdings (dba
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-04-14 8:52 AM EDT | Neural Therapeutics Inc.
Ruvidar More Effective in the Treatment of Herpes than FDA-Approved Treatments
Toronto, Ontario--(Newsfile Corp. - April 10, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers,...
Technology, Biotechnology, Healthcare and Hospitals, Pharmaceuticals
2025-04-10 7:00 AM EDT | Theralase Technologies Inc.
NervGen Provides Quarterly "At-The-Market" Equity Program Update
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today provided a quarterly update with respect to the Company's previously announced at-the-market equity program (the "ATM Program") launched on December...
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2025-04-09 5:53 PM EDT | NervGen Pharma Corp.

Have you heard? TMX Group has acquired Newsfile

Pharmaceuticals News

Press Releases from Pharmaceuticals Companies

Newsroom

RSS Feeds

Tell your pharmaceuticals story, report your results

Cookie Settings

Have you heard? TMX Group has acquired Newsfile

Tell your pharmaceuticals story, report your results